GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (STU:4RM) » Definitions » Gross Margin %

Catheter Precision (STU:4RM) Gross Margin % : 94.67% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Catheter Precision Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Catheter Precision's Gross Profit for the three months ended in Mar. 2024 was €0.07 Mil. Catheter Precision's Revenue for the three months ended in Mar. 2024 was €0.08 Mil. Therefore, Catheter Precision's Gross Margin % for the quarter that ended in Mar. 2024 was 94.67%.


The historical rank and industry rank for Catheter Precision's Gross Margin % or its related term are showing as below:

STU:4RM' s Gross Margin % Range Over the Past 10 Years
Min: -6990.91   Med: 3.06   Max: 94.31
Current: 94.31


During the past 8 years, the highest Gross Margin % of Catheter Precision was 94.31%. The lowest was -6990.91%. And the median was 3.06%.

STU:4RM's Gross Margin % is ranked better than
97.13% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.9 vs STU:4RM: 94.31

Catheter Precision had a gross margin of 94.67% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Catheter Precision was 0.00% per year.


Catheter Precision Gross Margin % Historical Data

The historical data trend for Catheter Precision's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision Gross Margin % Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial -22.94 -738.03 -7,163.16 -1,069.23 93.33

Catheter Precision Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.61 92.13 95.20 94.87 94.67

Competitive Comparison of Catheter Precision's Gross Margin %

For the Medical Devices subindustry, Catheter Precision's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catheter Precision's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Catheter Precision's Gross Margin % falls into.



Catheter Precision Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Catheter Precision's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.4 / 0.405
=(Revenue - Cost of Goods Sold) / Revenue
=(0.405 - 0.027) / 0.405
=93.33 %

Catheter Precision's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=0.1 / 0.075
=(Revenue - Cost of Goods Sold) / Revenue
=(0.075 - 0.004) / 0.075
=94.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Catheter Precision  (STU:4RM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Catheter Precision had a gross margin of 94.67% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Catheter Precision Gross Margin % Related Terms

Thank you for viewing the detailed overview of Catheter Precision's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Catheter Precision (STU:4RM) Business Description

Traded in Other Exchanges
Address
1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.

Catheter Precision (STU:4RM) Headlines

No Headlines